Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  hexamethylene bisacetamide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-13 of 13 for your search:
Start Over
Phase II Chemotherapy with HMBA in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemias
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: JHOC-87051401, NCI-T87-0130C, T87-0130
Phase II Chemotherapy with HMBA in Patients with Malignant Melanoma (Summary Last Modified 12/88)
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: MSKCC-8774, NCI-T87-0079C, T87-0079
Phase II Chemotherapy with Hexamethylene Bisacetamide in Patients with Myelodysplastic Syndromes and AML
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: MSKCC-87117A, DFCI-86133, NCI-T87-0092C, T87-0092
Phase II Chemotherapy with HMBA in Patients with Oral Leukoplakia (Summary Last Modified 08/88)
Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UMCC-8729, NCI-T88-0011C, T88-0011
Phase II Chemotherapy with Hexamethylene Bisacetamide in Patients with Stage III/IV non-Small Cell Lung Cancer (Summary Last Modified 03/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-88129, NCI-T88-0233C, T88-0233
Phase II Trial of HMBA with Albuterol/Theophylline in Patients with Advanced non-Small Cell Lung Cancer (Summary Last Modified 11/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-90174A3, NCI-T90-0240D, T90-0240
Phase I Study of Hexamethylene Bisacetamide in Patients with Advanced Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: 20 to 75
Sponsor: NCI
Protocol IDs: JHOC-8434, NCI-T84-0447W, T84-0447
Phase I Evaluation of Hexamethylene Bisacetamide in Patients with Solid Tumors
Phase: Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: UMCC-8423, NCI-T84-0443W, T84-0443
Phase I Evaluation of Hexamethylene Bisacetamide in Patients with Advanced Solid Tumors (Summary Last Modified 10/90)
Phase: Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: MSKCC-8587, NCI-T85-0222W, T85-0222
Phase I Chemotherapy with Continuous Infusion Hexamethylene Bisacetamide in Patients with Solid Tumors (Summary Last Modified 09/88)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UMCC-8533, NCI-T86-0006W, T86-0006
Phase I Chemotherapy with Hexamethylene Bisacetamide in Patients with Advanced Solid Tumors (Summary Last Modified 02/89)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WRAMC-8602, NCI-T86-0078O, T86-0078
Phase I Study of Chronic, Low-Dose, Oral HMBA in Patients with Recurrent Carcinoma in Situ of the Urinary Bladder (Summary Last Modified 08/90)
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: MSKCC-8831, NCI-T87-0247C, T87-0247
Phase I Trial of Oral HMBA/TRA in Patients with Myelodysplastic Syndrome (Summary Last Modified 11/92)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UMCC-9113, NCI-T91-0108C, T91-0108
Start Over